General Nephrology

General Nephrology

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

George L. Bakris, M.D., Rajiv Agarwal, M.D., Stefan D. Anker, M.D., Ph.D., Bertram Pitt, M.D., Luis M. Ruilope, M.D., Peter Rossing, M.D., Peter Kolkhof, Ph.D., Christina Nowack, M.D., Patrick Schloemer, Ph.D., Amer Joseph, M.B., B.S., and Gerasimos Filip
Google Plus
LinkedIn

Dapagliflozin in Patients with Chronic Kidney Disease

Hiddo J.L. Heerspink, Ph.D., Bergur V. Stefánsson, M.D., Ricardo Correa-Rotter, M.D., Glenn M. Chertow, M.D., Tom Greene, Ph.D., Fan-Fan Hou, M.D., Johannes F.E. Mann, M.D., John J.V. McMurray, M.D., Magnus Lindberg, M.Sc., Peter Rossing, M.D., C. David S
2020 Oct 8;383(15):1436-1446
Google Plus
LinkedIn

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Michael Walsh, M.D. et al for the PEXIVAS Investigators
N Engl J Med 2020; 382:622-631
Google Plus
LinkedIn

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis

Chen N, Hao C, Liu BC, Lin H, Wang C, Xing C, Liang X, Jiang G, Liu Z, Li X, Zuo L, Luo L, Wang J, Zhao MH, Liu Z, Cai GY, Hao L, Leong R, Wang C, Liu C, Neff T, Szczech L, Yu KP.
N Engl J Med. 2019 Sep 12;381(11):1011-1022. doi: 10.1056/NEJMoa1901713. Epub 2019 Jul 24
Google Plus
LinkedIn

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

ernando C. Fervenza, M.D., Ph.D., Gerald B. Appel, M.D., Sean J. Barbour, M.D., Brad H. Rovin, M.D., Richard A. Lafayette, M.D., Nabeel Aslam, M.D., Jonathan A. Jefferson, M.D., Patrick E. Gipson, M.D., Dana V. Rizk, M.D., John R. Sedor, M.D., James F. Si
https://www.ncbi.nlm.nih.gov/pubmed/31269364
Google Plus
LinkedIn

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, M.B., B.S., Ph.D., Meg J. Jardine, M.B., B.S., Ph.D., Bruce Neal, M.B., Ch.B., Ph.D., Severine Bompoint, B.Sc., Hiddo J.L. Heerspink, Pharm.D., Ph.D., David M. Charytan, M.D., Robert Edwards, M.P.H., Rajiv Agarwal, M.D., George Bakris, M.D
Google Plus
LinkedIn

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott, M.D., Itamar Raz, M.D., Marc P. Bonaca, M.D., M.P.H., Ofri Mosenzon, M.D., Eri T. Kato, M.D., M.P.H., Ph.D., Avivit Cahn, M.D., Michael G. Silverman, M.D., M.P.H., Thomas A. Zelniker, M.D., Julia F. Kuder, M.A., Sabina A. Murphy, M.P.H
Google Plus
LinkedIn

Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease

Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Perrone RD, Koch G, Ouyang J, McQuade RD, Blais JD, Czerwiec FS, Sergeyeva O; REPRISE Trial Investigators.
N Engl J Med. 2017 Nov 4
Google Plus
LinkedIn

Outcomes after Angiography with Sodium Bicarbonate and Acetylcysteine

Weisbord SD, Gallagher M, Jneid H, Garcia S, Cass A, Thwin SS, Conner TA, Chertow GM, Bhatt DL, Shunk K, Parikh CR, McFalls EO, Brophy M, Ferguson R, Wu H, Androsenko M, Myles J, Kaufman J, Palevsky PM; PRESERVE Trial Group
N Engl J Med. 2017 Nov 12. doi: 10.1056/NEJMoa1710933
Google Plus
LinkedIn

Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes

Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, Johansen OE, Woerle HJ, Broedl UC, Zinman B; EMPA-REG OUTCOME Investigators
N Engl J Med. 2016 Jul 28;375(4):323-34. doi: 10.1056/NEJMoa1515920
Google Plus
LinkedIn

Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus: Cardiovascular and Kidney Effects, Potential Mechanisms, and Clinical Applications

Hiddo J.L. Heerspink, Bruce A. Perkins, David H. Fitchett, Mansoor Husain, David Z. I. Cherney
Circulation. 2016 Sep 6;134(10):752-72
Google Plus
LinkedIn

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy

Ayoub I, Hebert L Rovin BH
N Engl J Med. 2015 Dec 3;373(23):2225-36
Google Plus
LinkedIn

Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis

Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaître O, Cohen P, Maurier F, Decaux O, Ninet J, Gobert P, Quémeneur T, Blanchard-Delaunay C, Godmer P, Puéchal X, Carron PL, Hatron PY, Limal N, Hamidou M, Ducret M, Daugas E, Papo T, Bonnotte B, Mahr A, R
N Engl J Med. 2014 Nov 6;371(19):1771-80
Google Plus
LinkedIn

[12 3 4  >>  
ukidneyisup